BOSTON (Reuters) – The U.S. Justice Department on Wednesday sued Regeneron Pharmaceuticals Inc (REGN.O), accusing it of using a charity that helps cover Medicare patients’ drug costs as a means to pay kickbacks for using its expensive macular degeneration drug Eylea.

The government filed a lawsuit against the company in federal court in Boston, the latest case to result from an industry-wide probe of drugmakers’ financial support of patient assistance charities.

Drug companies are prohibited from subsidizing co-payments for patients enrolled in the government healthcare program for those aged 65 and older. Companies may donate to non-profits providing co-pay assistance as long as they are independent.

But the lawsuit said Tarrytown, New York-based Regeneron following the launch of Eylea in 2011 began funneling tens of millions of dollars through a patient assistance foundation to ensure virtually no one on Medicare had to pay co-pays.

The lawsuit said the scheme helped Regeneron boost sales for the drug, which typically costs over $10,000 per year. From 2013 to 2014, when the scheme was operating, Medicare paid $1.9 billion for Eylea, the lawsuit said.

Regeneron in a statement said it would vigorously defend itself. “We do not believe there is any merit to the complaint,” the company said.

Its stock price midday Wednesday was $604.62, down 3.84%.

The lawsuit follows an investigation that has resulted in more than $865 million in settlements with drugmakers and charities, including the foundation the government says Regeneron used, Good Days, previously known as the Chronic Disease Fund.

Good Days in October agreed to pay $2 million to resolve allegations it conspired with five other companies including Novartis AG to enable them to pay kickbacks to Medicare patients using their drugs. It did not admit wrongdoing.

The case is U.S. v. Regeneron Pharmaceuticals Inc, U.S. District Court, District of Massachusetts, No. 20-11217.

Reporting by Nate Raymond in Boston; Editing by Chizu Nomiyama, Tom Brown and David Gregorio

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Saudi Aramco shares open 10% lower as the oil price crumbles

DUBAI (Reuters) – Shares in Saudi Aramco (2222.SE) plunged 10% in opening trade on Monday, following a sharp drop in oil prices after Saudi Arabia slashed its official selling prices for crude and set out plans for a dramatic increase…

ECB gives another shot of stimulus as economy reels

FRANKFURT (Reuters) – The European Central Bank approved a bigger-than-expected expansion of its stimulus package on Thursday to prop up an economy plunged by the coronavirus pandemic into its worst recession since World War Two. Just months after a raft…

Oil skids after Saudi price cuts, demand optimism fades

SINGAPORE (Reuters) – Oil prices dropped more than $1 a barrel on Monday, hitting their lowest since July, after Saudi Arabia made the deepest monthly price cuts for supply to Asia in five months as optimism about demand recovery cooled…

P&G expects coronavirus outbreak to hit current-quarter revenue, profit

(Reuters) – Procter & Gamble Co (PG.N) said on Thursday its current-quarter revenue and profit would take a hit from supply chain disruptions and weak demand due to the coronavirus outbreak in China, the consumer goods company’s second-biggest market. The…